We serve Chemical Name:ethyl 3-oxo-2-(thiophene-2-carbonyl)butanoate CAS:13892-51-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 3-oxo-2-(thiophene-2-carbonyl)butanoate
CAS.NO:13892-51-8
Synonyms:3-oxo-2-(thiophene-2-carbonyl)-butyric acid ethyl ester
Molecular Formula:C11H12O4S
Molecular Weight:240.27600
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:346.6ºC at 760mmHg
Density:1.238g/cm3
Index of Refraction:1.526
PSA:88.68000
Exact Mass:240.04600
LogP:1.69910
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-oxo-2-(thiophene-2-carbonyl)-butyric acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-oxo-2-(thiophene-2-carbonyl)-butyric acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-oxo-2-(thiophene-2-carbonyl)-butyric acid ethyl ester Use and application,3-oxo-2-(thiophene-2-carbonyl)-butyric acid ethyl ester technical grade,usp/ep/jp grade.
Related News: The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. N-(4-(1-hydroxy-6-nitro-1H-benzo[d]imidazol-2-yl)phenyl)-3-methoxybenzamide manufacturers the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment. 1ref-Dimethylamino-2cis-aethyl-1-aethyl-mercaptoaethen suppliers This commercial API license is incredibly important as it marks the next phase in our growth and enables us to support customers from concept to commercialization. We are now able to fill the gap in the market for small-scale commercial API requirements while maintaining our expertise in delivering early-stage programs.” (2R,3R)-2-(4-acetoxyphenyl)chromane-3,5,7-triyl triacetate vendor & factory Besides McNamara’s hire, GSK said it’s expected to name a chair for the OTC firm later this year, who will then establish the board.,the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment.
